IMMUNIC, INC. Earnings Per Share Diluted

• IMMUNIC, INC. showed an increase of +38.0% in Earnings Per Share Diluted from 2024 to 2025.
• This data is from IMMUNIC, INC.'s annual report (Form 10-K), filed with the SEC on February 26, 2026.
• XBRL data for this metric is available from 2020 to 2025 (6 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
• Quarterly values from 10-Q filings: Q1 2020: $0.79 (loss) per share | Q2 2020: $0.90 (loss) per share | Q3 2020: $0.70 (loss) per share | Q4 2020: $0.53 (loss) per share | Q1 2021: $1.63 (loss) per share | Q2 2021: $0.82 (loss) per share | Q3 2021: $0.76 (loss) per share | Q4 2021: $0.81 (loss) per share | Q1 2022: $0.74 (loss) per share | Q2 2022: $0.72 (loss) per share | Q3 2022: $0.69 (loss) per share | Q1 2023: $0.58 (loss) per share | Q2 2023: $0.54 (loss) per share | Q3 2023: $0.51 (loss) per share | Q1 2024: $0.30 (loss) per share | Q2 2024: $0.21 (loss) per share | Q3 2024: $0.24 (loss) per share | Q1 2025: $0.25 (loss) per share | Q2 2025: $0.20 (loss) per share | Q3 2025: $0.13 (loss) per share.
• Over the full 6 years of available data (2020 to 2025), IMMUNIC, INC.'s Earnings Per Share Diluted has grown by 77.9%.
• Historical annual values: Fiscal year 2025: $0.62 (loss) per share | Fiscal year 2024: $1.00 (loss) per share | Fiscal year 2023: $2.11 (loss) per share | Fiscal year 2022: $3.78 (loss) per share | Fiscal year 2021: $3.93 (loss) per share | Fiscal year 2020: $2.81 (loss) per share.
• Data sourced from SEC EDGAR public filings as of August 6, 2026.

Last verified: August 6, 2026